2004: Janus Kinase Inhibitors (JAKs) and Jakinibs: From Bench to Bedside
This seminar will cover several topics, including: and overview of JAK-STAT signaling pathways, including their roles in cells that drive allergic inflammation; a description of current and prospective use of JAK kinase inhibitors (Jakinibs) in allergic diseases; and examples of how the use of the latest technologies (single-cell RNA-seq) can facilitate the choice of Jakininbs as a treatment in an immune system-mediated disease.
Credit claiming for this activity will be available through December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
- Nurse Practitioners
- Allied Health Professionals
Upon completion of this activity, participants should be able to:
- Summarize fundamental knowledge on JAK kinases and their substrates
- Describe clinical applications of JAK kinase inhibitors
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to1.00 Contact Hours.
CREDIT CLAIMING PERIOD
Credit claiming for this activity will expire at 11:59 pm on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at firstname.lastname@example.org
Activity-related questions should be directed to email@example.com.
- 1.00 AttendanceAttendance credit.
- 1.00 CECE credit.
- 1.00 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.